University of California - Irvine Medical Center
Orange, California, 92868, United States
NCT Number: NCT05835323
The purpose of this study is to collect descriptive performance data using the MONARCH Platform, Urology (a novel robotic device) to perform mini-percutaneous nephrolithotomy (kidney stone removal) procedures. Data gathered from this study will be used to optimize the robotic platform and inform training and education material for the future users.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Not applicable
Orange, California, 92868, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Pre-Operative Exclusion Criteria:
Intra-Procedure Exclusion Criteria:
Eligible participants will be enrolled to undergo robotic-assisted PCNL using the MONARCH Platform, Urology for the removal of kidney stones. The MONARCH Platform, Urology is a novel flexible robotic device that enables the clinician to obtain both transurethral and percutaneous access to a participant's kidney under continuous visualization for therapeutic application (for example, stone removal).
Time frame: Day of Procedure
Percentage of participants in whom the kidney stone treatment and removal procedure could be successfully completed with the MONARCH™ Platform, Urology.
Auris Health, Inc.
Industry
Initial Experience of the Treatment of Kidney Stones With the MONARCH™ Platform, Urology
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269108
Calculi, Female Urogenital Diseases
Cairo, Egypt
View Trial DetailsNCT05088213
Calculi, Female Urogenital Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT03855787
Calculi, Female Urogenital Diseases
Los Angeles, California, United States
View Trial DetailsNCT05701098
Calculi, Female Urogenital Diseases
San Diego, California, United States
View Trial Details